Clinical Trials on Erythemato-telangiectatic Rosacea
Total 536 results
-
Novartis PharmaceuticalsCompletedErythemato-telangiectatic RosaceaUnited States
-
Tampere University HospitalTampere University of TechnologyCompletedRosacea | TelangiectasiaFinland
-
Galderma R&DCompletedErythematous RosaceaUnited States
-
Vicept Therapeutics, Inc.AccentureCompletedErythematous (Type One) RosaceaUnited States
-
University Hospital, BonnNovartisCompletedType 2 Idiopathic Macular TelangiectasiaGermany
-
The Lowy Medical Research Institute LimitedActive, not recruiting
-
Neurotech PharmaceuticalsCompletedMacular TelangiectasiaUnited States, Australia
-
Skin Laser & Surgery SpecialistsGalderma R&DTerminatedErythema and Flushing Associated With Rosacea
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedIdiopathic Juxtafoveal TelangiectasiaUnited States
-
Paul S. BernsteinCompletedIdiopathic Juxtafoveal TelangiectasiaUnited States
-
ThromboGenicsCompletedRetinal Telangiectasis | Idiopathic Juxtafoveal Retinal TelangiectasiaFrance, Switzerland
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
Centre Hospitalier Universitaire DijonRecruitingMacular TelangiectasiaFrance
-
University of California, San DiegoCompletedPapulopustular RosaceaUnited States
-
The Lowy Medical Research Institute LimitedActive, not recruitingMacular Telangiectasia Type 2United States, United Kingdom
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Manhattan Eye, Ear & Throat HospitalAlcon ResearchCompletedIdiopathic Perifoveal TelangiectasiaUnited States
-
National Eye Institute (NEI)CompletedMacular TelangiectasiaUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Hospices Civils de LyonCompletedHHT | Hemorrhagic Hereditary TelangiectasiaFrance
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Johns Hopkins UniversityGenentech, Inc.Completed
-
Derzhavin Tambov State UniversityCompletedSclerotherapyRussian Federation
-
Ulthera, IncCompleted
-
Grupo de Cirurgia VascularUnknown
-
Galderma R&DCompletedErythema | RosaceaUnited Kingdom, Germany, Sweden
-
Galderma R&DCompleted
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
AllerganCompletedErythema | RosaceaUnited States
-
AllerganCompletedErythema | RosaceaUnited States
-
Galderma R&DCompletedRosaceaUnited States
-
Actavis Inc.Watson Laboratories, Inc.Completed
-
AllerganCompletedErythema | RosaceaUnited States
-
AllerganCompleted
-
National Eye Institute (NEI)CompletedTelangiectasiaUnited States
-
National Eye Institute (NEI)CompletedTelangiectasiaUnited States
-
University of California, IrvineTerminatedRosacea | Port-Wine Stain | Telangiectasia | AngiomaUnited States
-
Xijing HospitalCompleted
-
Zealand University HospitalCompleted
-
Galderma R&DCompletedErythema | RosaceaUnited States
-
Padagis LLCCompleted
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
AllerganCompletedErythema | RosaceaUnited States
-
AllerganCompletedErythema | RosaceaUnited States
-
Hospices Civils de LyonCompletedHemorrhagic Hereditary TelangiectasiaFrance
-
Vaderis Therapeutics AGRecruitingHereditary Hemorrhagic Telangiectasia (HHT)United States, Spain, France, Belgium, Netherlands, Italy
-
Asociación para Evitar la Ceguera en MéxicoWithdrawn
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of Pittsburgh; Duke University; Barrow... and other collaboratorsActive, not recruitingHereditary Hemorrhagic Telangiectasia (HHT)Canada